Table 4 |
||||||
|
Correlations with serum resistin levels |
||||||
|
All patients |
Sepsis |
Non-sepsis |
||||
|
|
|
|
||||
|
Parameters |
r |
P |
r |
P |
r |
P |
|
|
||||||
|
Markers of inflammation |
||||||
|
IL-6 |
0.477 |
< 0.001 |
0.289 |
0.004 |
0.671 |
< 0.001 |
|
IL-10 |
0.273 |
0.002 |
0.231 |
0.027 |
ns |
|
|
TNF-α |
0.509 |
< 0.001 |
0.419 |
< 0.001 |
0.687 |
< 0.001 |
|
CRP |
0.510 |
< 0.001 |
0.395 |
< 0.001 |
0.389 |
0.012 |
|
Procalcitonin |
0.638 |
< 0.001 |
0.594 |
< 0.001 |
0.458 |
0.003 |
|
Markers of organ function |
||||||
|
Creatinine |
0.462 |
< 0.001 |
0.420 |
< 0.001 |
0.602 |
< 0.001 |
|
Cystatin C |
0.442 |
< 0.001 |
0.404 |
< 0.001 |
ns |
|
|
Lactate |
ns |
0.286 |
0.006 |
ns |
||
|
PCHE |
-0.269 |
0.002 |
-0.280 |
0.006 |
ns |
|
|
Bilirubin |
0.221 |
0.013 |
0.224 |
0.035 |
ns |
|
|
Markers of metabolism |
||||||
|
Protein |
-0.199 |
0.02 |
ns |
ns |
||
|
fT3 |
-0.319 |
< 0.001 |
-0.252 |
0.016 |
ns |
|
|
fT4 |
-0.276 |
0.001 |
-0.229 |
0.028 |
ns |
|
|
Cholesterol |
-0.245 |
0.004 |
-0.296 |
0.003 |
ns |
|
|
HDL |
-0.277 |
0.002 |
-0.254 |
0.019 |
ns |
|
|
LDL |
-0.359 |
< 0.001 |
-0.378 |
< 0.001 |
ns |
|
|
Lp(a) |
ns |
-0.223 |
0.040 |
ns |
||
|
Glucose |
-0.320 |
< 0.001 |
ns |
ns |
||
|
Insulin |
-0.209 |
0.02 |
ns |
ns |
||
|
HOMA IR |
0.314 |
< 0.001 |
ns |
ns |
||
|
PO4 |
0.321 |
< 0.001 |
0.308 |
0.003 |
0.417 |
0.008 |
|
Cortisol |
0.312 |
0.001 |
0.275 |
0.010 |
ns |
|
|
Parathormone |
0.212 |
0.019 |
0.228 |
0.033 |
ns |
|
|
Clinical scoring |
||||||
|
APACHE II |
ns |
ns |
0.481 |
0.005 |
||
|
|
||||||
|
r = correlation coefficient; r and P values by Spearman rank correlation. APACHE = Acute Physiology and Chronic Health Evaluation;CRP = C-reactive protein; fT3 = free triiodo-thyronine; fT4 = free thyroxine; HDL = high-density lipoprotein; HOMA IR = homeostasis model assessment index of insulin resistance; IL = interleukin; LDL = low-density lipoprotein; Lp(a) = lipoprotein (a); ns = not significant; PCHE = pseudocholinesterase; PO4 = phosphate; TNF-α = tumor necrosis factor α. |
||||||
|
Koch et al. Critical Care 2009 13:R95 doi:10.1186/cc7925 |
||||||